Merck & Co Inc. said on Tuesday that the U.S. Food and Drug Administration approved its immunotherapy Keytruda as a treatment for an early form of tough-to-treat breast cancer in combination with chemotherapy. The FDA approval is for treating triple-negative breast cancer (TNBC), an aggressive form of the disease with an increased risk of recurrence….

Merck & Co said on Wednesday it would supply about 60,000–100,000 doses of its experimental COVID-19 treatment to the U.S. government for up to about $356 million. The agreement will help support advanced development and large-scale manufacturing of the company’s investigational therapeutic MK-7110 to treat hospitalized patients with severe or critical COVID-19, the U.S. Department…